Pulsar International Limited has announced its unaudited standalone financial results for the quarter and nine months ended December 31, 2025. The company's board of directors approved these results during a meeting held on February 14, 2026, in compliance with regulatory requirements.

Board Meeting Details

The board meeting was conducted on February 14, 2026, commencing at 3:00 PM and concluding at 3:50 PM. During this meeting, the directors adopted and approved the standalone unaudited financial results for both the quarter and nine months ended December 31, 2025.

Financial Results Overview

The company's financial statements show various operational metrics for the reporting period. The total income for the quarter stood at ₹3963.86 lakhs, while for the nine months period it reached ₹5511.44 lakhs. The company reported expenses including purchase of stock-in-trade amounting to ₹5075.00 lakhs for the quarter and ₹7088.78 lakhs for the nine months period.

Auditor Review

Shweta Jain & Co LLP, the company's statutory auditors, have provided limited review reports on the standalone unaudited financial results for both the quarter and nine months ended December 31, 2025. The auditors confirmed that nothing came to their attention that would cause them to believe the financial results were not prepared in accordance with applicable accounting standards.

Regulatory Compliance

The announcement was made pursuant to Regulation 33 and Regulation 30 read with Part-A of Schedule III of SEBI (LODR) Regulations, 2015. The company has fulfilled its disclosure obligations by informing the stock exchanges about the outcome of the board meeting and the approval of financial results.

Management Leadership

The results were announced under the leadership of Arvind Parmar, who serves as the Chairman and Managing Director of Pulsar International Limited. The company continues to maintain its commitment to transparent financial reporting and regulatory compliance in line with stock exchange requirements.

Pulsar International Limited has successfully completed a significant rights issue, with its Rights Issue Committee approving the allotment of substantial equity shares to eligible shareholders. The committee meeting, held on January 21, 2026, at the company's registered office in Ahmedabad, Gujarat, marked a crucial milestone in the company's capital expansion plans.

Rights Issue Details and Structure

The Rights Issue Committee approved the allotment of 35.69 crore fully paid-up equity shares with a face value of ₹1.00 each. The rights issue was structured in a 5:1 ratio, meaning eligible shareholders received 5 rights equity shares for every 1 fully paid-up equity share they held on the record date.

Committee Meeting and Approval Process

The Rights Issue Committee meeting commenced at 7:00 PM and concluded at 7:20 PM on January 21, 2026, at the company's registered office located at 16 Vibrant Mega Industrial Park, Vehlal, Ahmedabad, Gujarat. The allotment was conducted pursuant to the Letter of Offer dated December 23, 2025, and followed the Basis of Allotment approved by BSE Limited, which served as the designated stock exchange for this issue.

Impact on Share Capital Structure

Following the completion of the rights issue allotment, Pulsar International Limited's paid-up equity share capital has been restructured significantly. The company's enhanced capital position reflects the successful completion of the rights offering to existing shareholders.

Administrative Actions

As part of the rights issue completion process, the committee also approved the extinguishment of lapsed rights entitlements and deactivation of the ISIN for rights entitlements (INE183U20014). This administrative action ensures proper closure of the rights issue process and maintains accurate records for all stakeholders.

The company has informed BSE Limited about these developments in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring full transparency and regulatory adherence throughout the rights issue process.